Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study.
Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patients over 18 years old
2. Chronic kidney disease patients with eGFR \< 60 mL/min/1.73 m²
3. Patients with hyperkalemia detected in the emergency department
4. Patients willing to participate in the study and who sign the consent form
Exclusion Criteria:
1. Patients under 18 years old
2. Patients who do not wish to participate in the study
3. Patients without chronic kidney damage
4. Patients without detected hyperkalemia
5. Patients needing cardiopulmonary resuscitation due to hyperkalemia
Primary outcome measure(s)
ECHO changes — from enrollment to the end of follow up duration of 30 days Describing echocardiograhic (ECHO) changes of isolated hyperkalemia in patients with chronic kidney disease (CKD)
Trial sites (1)
Facility
City
Region
Status
Etlik City Hospital
Ankara
Turkey (Türkiye)
Recruiting
More Saglik Bilimleri Universitesi trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.